Underuse of recommended treatments among people living with treatment-resistant psychosis

Underuse of recommended treatments among people living with treatment-resistant psychosis

BackgroundInternational guidelines recommend that individuals with treatment-resistant psychosis must be treated with clozapine. ECT has also been reported to improve symptom profiles. Identification of clozapine and/or ECT use in real-world practice enables understanding of the extent to which this...

Full description

Bibliographic Details
Main Authors:	Julia M. Lappin, Kimberley Davies, Maryanne O'Donnell, Ishan C. Walpola
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Psychiatry
Subjects:	psychosis treatment-resistance clozapine ECT schizophrenia
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2022.987468/full

Similar Items

Editorial: Treatment resistance in psychotic disorders
by: Santanu Nath, et al.
Published: (2023-03-01)

Managing treatment resistance in schizophrenia: A joint study in Hong Kong and Singapore
by: Shushan Zheng, et al.
Published: (2022-10-01)

DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophrenia
by: Eilis Hannon, et al.
Published: (2021-02-01)

What is the best approach for patients with prolonged duration of untreated psychosis (DUP) - about 2 clinical cases with dup longer than 10 years
by: R. Gomes, et al.
Published: (2021-04-01)

Clozapine prescribing during follow-up of a first-episode psychosis cohort
by: R. Rowntree, et al.
Published: (2021-04-01)

Impact of medications, mood state, and electrode placement on ECT outcomes in treatment-refractory psychosis
by: Nicholas J. Ainsworth, et al.
Published: (2022-09-01)

Clozapine in Treatment-Resistant Schizophrenia and Its Augmentation with Electroconvulsive Therapy in Ultra-Treatment-Resistant Schizophrenia
by: Vjekoslav Peitl, et al.
Published: (2023-04-01)

Closure beyond clozapine: successfully averting rebound symptoms in a patient with schizoaffective disorder and agranulocytosis
by: Alastair Green, et al.
Published: (2019-05-01)

Prevalence of treatment resistance and clozapine use in early intervention services
by: Imogen Stokes, et al.
Published: (2020-09-01)

Significant improvement of psychotic symptoms in treatment-resistant schizophrenia with clozapine in an adolescent with SHINE syndrome: a case report
by: Maxine Yang, et al.
Published: (2023-06-01)

Emerging Catatonia and Psychosis in Resolving COVID-19 Infection in an Adolescent
by: N. Choudhury, et al.
Published: (2022-06-01)

The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia
by: Licia Vellucci, et al.
Published: (2023-08-01)

Proof–of–concept evidence for high–density EEG investigation of sleep slow wave traveling in First-Episode Psychosis
by: Anna Castelnovo, et al.
Published: (2024-03-01)

Clozapine combination and augmentation strategies in patients with schizophrenia - recommendations from an international expert survey among the treatment response and resistance in psychosis (TRRIP) working group
by: Wagner, Elias, et al.
Published: (2021)

CLEAR – clozapine in early psychosis: study protocol for a multi-centre, randomised controlled trial of clozapine vs other antipsychotics for young people with treatment resistant schizophrenia in real world settings
by: C. Casetta, et al.
Published: (2024-02-01)

Double-blind, randomized, clinical trial of metformin as add-on treatment with clozapine in treatment of schizophrenia disorder
by: Paria Hebrani, et al.
Published: (2015-01-01)

Loxapine in patient with clozapine-resistant psychosis
by: Jennifer Erley, PharmD, MBA, BCPS, et al.
Published: (2021-07-01)

Machine Learning Algorithm-Based Prediction Model for the Augmented Use of Clozapine with Electroconvulsive Therapy in Patients with Schizophrenia
by: Hong Seok Oh, et al.
Published: (2022-06-01)

Effective and underprescribed: what about clozapine?
by: Helge H.O. Müller
Published: (2017-10-01)

A Synthetic Literature Review on the Management of Emerging Treatment Resistance in First Episode Psychosis: Can We Move towards Precision Intervention and Individualised Care?
by: Siân Lowri Griffiths, et al.
Published: (2020-11-01)

Clozapine-induced, dilated cardiomyopathy: a case report
by: Sarah Longhi, et al.
Published: (2017-07-01)

Sustained long-term improvement with clozapine in schizophrenia Clozapina na esquizofrenia grave: melhora duradoura e sustentada
by: RICARDO DE OLIVEIRA-SOUZA, et al.
Published: (1999-03-01)

Cannabis and risk of psychosis
by: M Drewe, et al.
Published: (2004-11-01)

Treatment-resistant schizophrenia : the relationship between clozapine plasma concentration and clinical outcome
by: I. Kammoun, et al.
Published: (2022-06-01)

Electroconvulsive therapy in treatment resistant schizophrenia: Old beacon of hope when nothing else works
by: C. Adão, et al.
Published: (2022-06-01)

Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial
by: Ming-Huan Zhu, et al.
Published: (2022-10-01)

Ethnic inequalities in treatment with clozapine
by: D. Fonseca De Freitas, et al.
Published: (2022-06-01)

Treatment resistant psychosis in children and adolescents and clozapine: Nuances
by: Jigyansa Ipsita Pattnaik, et al.
Published: (2023-02-01)

Catatonia: Clinical Overview of the Diagnosis, Treatment, and Clinical Challenges
by: Amber N. Edinoff, et al.
Published: (2021-11-01)

Clozapine point of care testing in acute psychiatry: A precision approach to treatment resistant psychosis
by: X. Boland, et al.
Published: (2021-04-01)

Prevalence of treatment resistant schizophrenia according to minima TRRIP criteria in a mental health catchment area in southern Spain
by: L.I. Muñoz-Manchado, et al.
Published: (2022-06-01)

Effect of Clozapine on DNA Methylation in Peripheral Leukocytes from Patients with Treatment-Resistant Schizophrenia
by: Makoto Kinoshita, et al.
Published: (2017-03-01)

Clozapine and paliperidone palmitate antipsychotic combination in treatment-resistant schizophrenia and other psychotic disorders: A retrospective 6-month mirror-image study
by: Miquel Bioque, et al.
Published: (2020-01-01)

Stigmatisation of schizophrenia, psychosis and autism in flemish newspapers
by: E. Thys, et al.
Published: (2021-04-01)

Augmentation strategies for treatment-refractory clozapine patients
by: O. Freudenreich
Published: (2021-04-01)

Psychosis in Women: Time for Personalized Treatment
by: Marianna Mazza, et al.
Published: (2021-12-01)

Neutropenia in patients under treatment with clozapine and COVID-19 infection
by: S. Bonaccorso, et al.
Published: (2021-04-01)

Cannabidiol versus placebo as adjunctive treatment in early psychosis: study protocol for randomized controlled trial
by: T. Dixon, et al.
Published: (2023-11-01)

Real-world effectiveness of admissions to a tertiary treatment-resistant psychosis service: 2-year mirror-image study
by: Cecilia Casetta, et al.
Published: (2020-09-01)

Psychosis treatment using Clozapine in velocardiofacial syndrome
by: Ana Raquel Faria, et al.
Published: (2022-09-01)